Viewing Study NCT02171195


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-02-26 @ 4:17 PM
Study NCT ID: NCT02171195
Status: COMPLETED
Last Update Posted: 2016-07-20
First Post: 2014-06-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
Sponsor: Bial - Portela C S.A.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-07
Start Date Type: None
Primary Completion Date: 2000-10
Primary Completion Date Type: ACTUAL
Completion Date: 2000-10
Completion Date Type: ACTUAL
First Submit Date: 2014-06-20
First Submit QC Date: None
Study First Post Date: 2014-06-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-11-28
Results First Submit QC Date: None
Results First Post Date: 2015-01-07
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-07-19
Last Update Post Date: 2016-07-20
Last Update Post Date Type: ESTIMATED